Cargando…
Impact of colchicine on mortality and morbidity in COVID-19: a systematic review
INTRODUCTION: Colchicine, because of its anti-inflammatory and possible anti-viral properties, has been proposed as potential therapeutic option for COVID-19. The role of colchicine to mitigate “cytokine storm” and to decrease the severity and mortality associated with COVID-19 has been evaluated in...
Autores principales: | Sanghavi, Devang, Bansal, Pankaj, Kaur, Ikwinder Preet, Mughal, Mohsin Sheraz, Keshavamurthy, Chandana, Cusick, Austin, Schram, Jennifer, Yarrarapu, Siva Naga S., Giri, Abhishek R., Kaur, Nirmaljot, Moreno Franco, Pablo, Abril, Andy, Aslam, Fawad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920395/ https://www.ncbi.nlm.nih.gov/pubmed/35258357 http://dx.doi.org/10.1080/07853890.2021.1993327 |
Ejemplares similares
-
INHALED NITRIC OXIDE IN COVID-19-INDUCED HYPOXEMIC RESPIRATORY FAILURE
por: NAGA YARRARAPU, SIVA, et al.
Publicado: (2021) -
Acute viral myositis complicated by rhabdomyolysis: a sole manifestation of COVID-19 infection
por: Mughal, Mohsin Sheraz, et al.
Publicado: (2021) -
EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA
por: ROY, ARCHANA, et al.
Publicado: (2021) -
Pantoea agglomerans Bacteremia: Is It Dangerous?
por: Kaur, Ikwinder Preet, et al.
Publicado: (2020) -
The prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in intensive care unit (ICU) healthcare personnel (HCP) and its implications—a single-center, prospective, pilot study
por: Mughal, Mohsin Sheraz, et al.
Publicado: (2020)